Results
|
|
1.
|
Rethinking Second-Line Therapy for Overactive Bladder to Improve Patient Access to Treatment Options. [Review] MedStar authors:
Year: 2021
Citation: - Obstetrics & Gynecology. 137(3):454-460, 2021 03 01.
Institution: - MedStar Washington Hospital Center
Department: - Obstetrics and Gynecology/Female Pelvic Medicine and Reconstructive Surgery
Medline publication type:
All authors: - Barnes HC, Bennett AT, Brown OE, Cardenas-Trowers OO, Chang OH, Escobar CM, Falk KN, Hall EF, Jeney SES, Mehta S, Menhaji K, Ringel NE, Sappenfield EC, Tellechea LM
|
|
|
2.
|
"First, Do No Harm"-Trainees' Observation of Risk Reduction in the Treatment of Overactive Bladder. MedStar authors:
Year: 2021
Citation: - Female Pelvic Medicine & Reconstructive Surgery. 27(1):2-4, 2021 01 01.
Institution: - MedStar Washington Hospital Center
Department: - Obstetrics and Gynecology/Female Pelvic Medicine and Reconstructive Surgery
Medline publication type:
All authors: - Barnes H, Bennett AT, Brown OE, Cardenas-Trowers OO, Chang OH, Escobar C, Falk KN, Hall EF, Jeney SES, Mehta S, Menhaji K, Ringel NE, Sappenfield EC, Tellechea LM
|
|
|
3.
|
Association of Antihypertensives That Stimulate vs Inhibit Types 2 and 4 Angiotensin II Receptors With Cognitive Impairment. MedStar authors:
Year: 2022
Citation: - JAMA Network Open. 5(1):e2145319, 2022 01 04.
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Bress AP, Bryan N, Cheung AK, Cohen JB, Derington CG, Ghazi L, Greene TH, Herrick JS, King JB, Marcum ZA, Pajewski NM, Sonnen JA, Supiano MA, Systolic Blood Pressure Intervention Trial (SPRINT) Research Group, Weintraub WS, Williamson J, Zhang C
|
